Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BRAVE Venture Capital is a Poland-based venture capital firm that invests in early-stage enterprises with global aspirations. Founded to enhance the value of companies through research and development, BRAVE operates the BRAVE Seed Fund and manages joint ventures such as the WARMIA I MAZUR CAPITAL FUND and KUJAWSKO-POMORSKIE FUNDUSZ KAPITAŁOWEGO in collaboration with Bank Gospodarstwa Krajowego and private investors. The firm is headquartered in Wrocław, Poland, and has a strong commitment to supporting innovators and scientists in commercializing their R&D results.
As of now, BRAVE manages a portfolio of 10 companies, focusing on sectors such as IoT, healthcare, biotech, and renewable energy. The firm emphasizes the importance of research-driven projects and aims to provide not only financial support but also access to a robust ecosystem that includes mentorship and strategic guidance. BRAVE's investment horizon typically spans from 4 to 14 years, reflecting its long-term commitment to the growth of its portfolio companies.
BRAVE Venture Capital focuses on investments in sectors including the Internet, IoT & hardware, renewable energy sources, and life sciences, particularly MedTech and BioTech. The firm seeks early-stage projects, preferably with prototypes, and offers check sizes ranging from $50,000 to $500,000. Geographic focus includes both Poland and broader European markets, with an emphasis on supporting startups that have global ambitions.
The organization prioritizes research-driven companies that demonstrate potential for scalable commercialization of innovative technologies. BRAVE provides non-financial support through its ecosystem in Poland and Scandinavia, enhancing the growth potential and market readiness of its investments. The firm looks for founders who are deeply involved in their projects and who possess a strong vision for their companies.
BRAVE Venture Capital's portfolio includes a diverse range of innovative companies:
Morten Karnoe - VC Partner. Morten has a background as a professor at Aalborg University and has served as the director of New Capital Markets Research at Stanford. He brings extensive experience in international commercialization and research networks.
Łukasz Feldman - Chairman of the Board. Łukasz is the managing partner and founder of BRAVE. He has co-founded and managed funds that support innovative projects, with experience financing ventures from seed stage to stock-exchange entry.
Albert Smektalski - Business Partner. Albert focuses on finance, strategic management, seed financing, and R&D. He has expertise in Industry 4.0, ICT/IoT, and MedTech.
Przemysław Federowicz - Partner. Przemysław has experience as a technology and investment operator, with a background in IT/e-commerce due diligence and private equity advisory.
Aleksander Mercik - Partner. Aleksander specializes in financial risk management and valuation, with a focus on blockchain applications in finance and operational supervision of portfolio companies.
To pitch BRAVE Venture Capital, startups should reach out via email at startups@brave.vc. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. BRAVE prefers to receive pitches through this channel rather than through unsolicited calls or meetings.
Startups can expect a response within a few weeks, depending on the volume of inquiries. A warm introduction is beneficial but not mandatory. The firm values clarity and detail in the pitch, as this helps them assess the potential of the startup quickly.
BRAVE Venture Capital operates the following funds:
In recent months, BRAVE Venture Capital has made several notable investments in innovative startups. The firm has backed applications for rehabilitation management and gamification platforms, reflecting its commitment to supporting technology-driven solutions.
BRAVE continues to expand its portfolio, which currently includes 10 companies across various sectors. The firm remains active in seeking new investment opportunities, particularly in the fields of MedTech and biotechnology.
What are BRAVE Venture Capital's investment criteria?
BRAVE focuses on early-stage companies in sectors such as IoT, healthcare, biotech, and renewable energy. They prefer projects with prototypes and a clear path to commercialization.
How can startups apply for funding from BRAVE?
Startups can pitch their ideas by emailing startups@brave.vc. They should include a detailed business plan and information about their team and technology.
What makes BRAVE different from other venture capital firms?
BRAVE provides not only financial support but also access to a robust ecosystem that includes mentorship and strategic guidance, particularly in Poland and Scandinavia.
What is the typical check size for investments?
BRAVE typically invests between $50,000 and $500,000 in early-stage companies.
What is the expected investment horizon?
The investment horizon for BRAVE is generally between 4 to 14 years, allowing for long-term growth and development of portfolio companies.
Does BRAVE participate in follow-on investments?
Yes, BRAVE supports follow-on rounds and public-funding opportunities for its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.